AzTrials
AzTrials

Fontan CirculationNCT06258382

Fontan Circulation and Reproductive Health in a National Swedish Cohort

An observational study of Fontan Circulation, run by Caroline Lilliecreutz at 15 sites in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In the Swedish registry for congenital heart defects, SWEDCON, over 230 patients with single-ventricle circulation are registered in the adult section. Congenital heart defects affect career choices, family planning, and leisure activities. Questions regarding heredity and pregnancy are common. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Fontan Circulation
What is being tested?
Questionnaires and functional test
How many people
600 participants
Where
15 sitesSweden
Study dates
1 Nov 2023to 1 Oct 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Approximately 200 patients with fontan circulation and their potential partners. Age and gender matched control groups.

Who may be able to join

  • Fontan circulation,
  • Age ≥18 years at inclusion,
  • Follow-up at specialist clinics,
  • Ability to fill in questionnaires in the Swedish language (no other alternative available) or
  • Partner of a person with Fontan circulation,
  • Age ≥18 years at inclusion
  • Ability to fill in questionnaires in the Swedish language (no other alternative available).
  • or •Age- and gender-matched individuals are recruited via the population registry. They must not have congenital heart disease.

Who cannot join

  • -

Trial locations and contacts

15 sites in 1 country.

Caroline Lilliecreutz, PhD, Docent contact

+46708731124

caroline.lilliecreutz@regionostergotland.se

15 sites in 1 country

Sweden15 sites, 15 recruiting
  • Sahlgrenska Academy, University of Gothenburg Sahlgrenska University Hospital

    Gothenburg

    Eva Furenäs, MD PhD, eva.furenas@vgregion.se,

    Not yet recruiting
  • Sahlgrenska University Hospital,

    Gothenburg

    Mårten Alkmark, MD PhD, marten.alkmark@vgregion.se

    Not yet recruiting
  • University Hospital, Linköping

    Linköping

    Alexsandra Trzebiatowska, MD, PhD,, Aleksandra.Trzebiatowska-Krzynska@regionostergotland.se,

    Not yet recruiting
  • Linköping University, University Hospital

    Linköping, Östergötland County, 58158 Linköping

    Caroline Lilliecreutz, PhD Associate professor, +46708731124, caroline.lilliecreutz@regionostergotland.se

    Not yet recruiting
  • Lund University Skåne University Hospital

    Lund, Skåne County

    Joanna Hlebowicz, Docent PhD, joanna.hlebowicz@med.lu.se

    Recruiting
  • Skåne University Hospital, Lund University

    Lund

    Emma von Wowern, MD PhD, emma.von_wowern@med.lu.se

    Not yet recruiting
  • Karolinska University Hospital

    Stockholm

    Eva Mattsson, Chief Physician, eva.mattsson@regionstockholm.se,

    Not yet recruiting
  • Karolinska University Hospital

    Stockholm

    Edit Nagy, MD, PhD, edit.nagy@regionstockholm.se

    Not yet recruiting
  • Karolinska University Hospital

    Stockholm

    Maria Sennström, MD PhD, maria.sennstrom@ki.se

    Not yet recruiting
  • University West, Drottning Silvia's Children's Hospital/Sahlgrenska University Hospital,

    Trollhättan

    Malin Berghammer, Professor, malin.berghammer@hv.se

    Not yet recruiting
  • Umeå University, Norrland University Hospital

    Umeå

    Bengt Johansson, Professor, bengt.johansson@umu.se

    Not yet recruiting
  • Umeå University, Norrlands University Hospital

    Umeå

    Ulrika Ottander, chief physician, ulrika.ottander@umu.se

    Not yet recruiting
  • Umeå University, Norrlands University Hospital

    Umeå

    Annika Bay, senior lecturer, Annika.bay@umu.se

    Not yet recruiting
  • Akademiska Hospital Uppsala.Uppsala University.

    Uppsala

    Anna-Karin Wikström, Professor, Anna-karin.wikstrom@kbh.uu.se

    Recruiting
  • Uppsala University, Akademiska Hospital

    Uppsala

    Christina Christersson, Associate Professor

    christina.christersson@medsci.uu.se

    Recruiting

Other trials in Sweden

About this study

In the Swedish registry for congenital heart defects, SWEDCON, over 230 patients with single-ventricle circulation are registered in the adult section.

Congenital heart defects affect career choices, family planning, and leisure activities. Questions regarding heredity and pregnancy are common.

Read more

The impact of Fontan circulation on reproductive health and fertility needs to be illuminated, and additional studies are required from both medical and psychosocial perspectives.Cognitive impairment is common among patients with congenital heart defects but is likely an overlooked cause of long-term illness.

Objective To study a large national population (n=200) of adults with Fontan circulation and their potential partners regarding.

  • the prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation (Study A).
  • the outcomes of pregnancy, choice of delivery mode, and complications in patients with Fontan circulation (Study B).
  • the experiences and perceptions of becoming parents among women (n=20) and men (n=20), as well as elucidate reasoning and family planning among women and men (n=20) who have not become parents (Study C).
  • Investigate the prevalence and explanatory factors for (Sub-study D):
  • Fatigue
  • In-depth cognitive screening to describe specific cognitive functions such as auditory memory, visuospatial memory, attention, cognitive speed, and executive functions.

The aim of this research is to gain more knowledge in an area that has been relatively underexplored, thus improving care for women and men with congenital heart defects.

Read the detailed description

Every year, approximately 2000 children are born with congenital heart defects in Sweden. In a small percentage of these cases, the heart defects are so severe that they cannot be corrected to resemble or function like a healthy heart. Instead, these highly complex heart defects are operated on to establish "single-ventricle circulation," also known as Fontan circulation or TCPC circulation (total cavopulmonary connection). This means there is only one chamber in circulation, pumping blood into the body's main artery. To facilitate venous blood flow to the lungs for oxygenation and back to the heart chamber, high venous pressure and low resistance in the lung circulation are required.

This type of blood circulation can lead to severe complications later in life, including heart failure, low oxygen saturation, blood clot formation, liver cirrhosis, bleeding, protein-losing enteropathy, arrhythmias, and reduced physical capacity. In the Swedish registry for congenital heart defects, SWEDCON, over 230 patients with single-ventricle circulation are registered in the adult section.

Congenital heart defects affect career choices, family planning, and leisure activities. Questions regarding heredity and pregnancy are common. The severity of different heart defects varies and has varying degrees of impact on patients' daily lives. Pregnancy and childbirth exert significant stress on a woman and her body. Due to the increased metabolic needs of the fetus and the mother, hemodynamics change during a normal pregnancy, with approximately a 40-50% increase in cardiac output and plasma volume. Pregnancy is often well tolerated by women with congenital heart defects, but there might be an increased risk of complications associated with pregnancy and childbirth. Women with complex congenital heart defects have a higher risk of experiencing cardiovascular events during pregnancy compared to women with simpler congenital heart defects. There is also a greater risk of infertility for these women. The modified WHO classifications system (mWHO class I-IV) can be used to assess risk associated with pregnancy and childbirth for women with heart disease, where higher class is associated with increased morbidity and mortality. In Fontan circulation, the risk of complications during pregnancy is considered high if the woman is classified as mWHO III or IV. If a woman experiences complications due to Fontan circulation before pregnancy, she is classified as mWHO IV and will be discouraged from pregnancy due to a very high risk for both maternal and fetal complications. During pregnancy, there is an increased risk of arrhythmias, heart failure symptoms, and thrombosis. Miscarriage risk is high for women with Fontan circulation, and preterm delivery is common, often resulting in low birth weight for gestational age. There is also an increased risk of peripartum bleeding. It is recommended that patients with Fontan circulation have frequent check-ups during pregnancy and in the first weeks after delivery.

Some women with complex congenital heart defects choose not to undergo pregnancy due to their heart condition. Others choose to become pregnant despite being informed about the high risks and advice against pregnancy, which places high demands on the care and follow-up of these patients. How men with Fontan circulation perceive their parental abilities and the possibility of having children is poorly studied, as well as how a partner of a person with complex congenital heart defects thinks and reasons about parenthood.

The impact of Fontan circulation on reproductive health and fertility needs to be illuminated, and additional studies are required from both medical and psychosocial perspectives.

Cognitive impairment is common among patients with congenital heart defects but is likely an overlooked cause of long-term illness. Cognitive function and fatigue significantly affect all aspects of quality of life, including employment opportunities, educational level, and the ability to maintain meaningful social relationships, such as marriage. How this affects reproductive health is not fully understood.

Objective:

To study a large national population (n=200) of adults with Fontan circulation and their potential partners regarding.

  • the prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation (Study A).
  • the outcomes of pregnancy, choice of delivery mode, and complications in patients with Fontan circulation (Study B).
  • the experiences and perceptions of becoming parents among women (n=20) and men (n=20), as well as elucidate reasoning and family planning among women and men (n=20) who have not become parents (Study C).
  • Investigate the prevalence and explanatory factors for (Sub-study D):
  • Fatigue
  • In-depth cognitive screening to describe specific cognitive functions such as auditory memory, visuospatial memory, attention, cognitive speed, and executive functions.

Work Plan The study is a national study involving six national centers: Gothenburg, Linköping, Lund, Stockholm, Umeå and Uppsala. Each participating center includes all patients with Fontan circulation. This involves approximately 200 patients and their potential partners.

In Sweden, there are an estimated 40,000 adults with congenital heart defects. We have a unique national register for congenital heart defects, The Swedish Registry of Congenital Heart Disease (SWEDCON), which started in the 1990s with Grown Up Congenital Heart disease (GUCH) and expanded in 2009 to include pediatric cardiology, heart interventions, and now fetal cardiology in congenital heart defects.

Design: Observational study.

The aim of this research is to gain more knowledge in an area that has been relatively underexplored, thus improving care for women and men with congenital heart defects. It is relatively common for women with congenital heart defects to avoid pregnancy due to their heart condition. In cases of aortic valve and/or pulmonary valve disease, Tetralogy of Fallot, and transposition of the great arteries, up to a third of women reported they did not want to have children because of their heart condition .

Therefore, there is significant patient benefit in conducting research among women and men with congenital heart defects. By gaining more knowledge in a new and relatively unexplored area, care can be improved, enabling these women to give birth if they wish without having to avoid it due to their chronic disabilities. Women with less complex heart disease and better functional status can also benefit from new knowledge and improved care, especially since there is a link between maternal congenital heart defects and lower birth weight in infants.

Being tested
Questionnaires and functional test
Keywords
reproductive health, cognitive impairment, grown up heart disease
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionnaires and functional testOther

    Data will be collected from different sources. Questinnaires, Medical journal, Obstetrical records and functional tests

Study groups in NCT06258382
Study groupRoleWhat they receive
Male with Fontan circulationDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included-
Receives: Other: Questionnaires and functional test
Female with Fontan circulationDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included-
Receives: Other: Questionnaires and functional test
Partner to male with Fontan circulationDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included-
Receives: Other: Questionnaires and functional test
Partner to female with Fontan circulationDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included-
Receives: Other: Questionnaires and functional test
Male control groupDifferent data will be collected along with several questionnaires concerning reproductive health . Approximate 100 individuals will be included
Receives: Other: Questionnaires and functional test
Female control groupDifferent data will be collected along with several questionnaires concerning reproductive health. Approximate 100 individuals will be included
Receives: Other: Questionnaires and functional test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation

    Reproductive health questionnaire for Woman/reproductive health questionnaire for Man, and a questionnaire for the potential partner, designed for this study.

    International Index of Erectile Function (IIEF5) Female Sexual Function Index (FSFI) EQ-5D is an instrument to describe and measure health and health-related quality of life.

    Measured: 3 hours

Secondary outcomes (3)
  1. Obstetric, neonatal and cardiological variables before, during, and after pregnancy

    Cardiological complications during pregnancy, at delivery, first 6 months Pregnancy,Obstetric and Neonatal complications e.g.Gestational diabetes, Pregnancy-induced hypertension, Preeclampsia, Anemia,Thromboembolic event, hepatosis, Chorioamnionitis-other Relevant medication. Gestational week at partus Premature delivery Induction with indication, Delivery method; uncomplicated vaginal delivery, instrumental vaginal delivery, Cesarean section,Bleeding (ml) at partus, Birth trauma Placental retention, Maternal death.

    Admission to neonatal ward, Neonatal complications, Child malformations- Type-, Neonatal death, Birth weight, small for gestational age (SGA), large for gestational age (LGA), average for gestational age (AGA) Apgar

    Measured: 4 hours

  2. Experiences and perceptions of parenthood

    Thoughts, fears, and hopes,Information and knowledge before and during pregnancy, Follow-ups during pregnancy and their extent, Need for special contact at the clinic for congenital heart defects during pregnancy, Physical and mental well-being during and after childbirth ,Describe experiences and perceptions of parenthood in men Long-term follow-up; additional pregnancy, intervention, hospitalization for heart failure/arrhythmia/FALD/endocarditis/infection/stroke, transplantation, cardiovascular death, non-cardiovascular death after 2.5, 10, and 15 years .

    Control group: As control subjects, 200 age- and gender-matched individuals are recruited via the population registry. They must not have congenital heart disease. They will complete the same questionnaires as the study participants and will be asked questions about health status.

    Measured: 4 hours

  3. Cognitive function

    Multidimensional Fatigue Inventory (MFI-20) Montreal Cognitive Assessment (MoCA) SDMT - Symbol Digit Modalities Test. . TMT A and B - Trail Making Test. BVMT-R - Brief Visuospatial Memory Test. CWIT - Color Word Interference Test. M. FAS - Verbal Fluency Test. DEX - Dysexecutive Questionnaire. . HADs- Hospital Anxiety and Depression Scale BDI II- Beck Depression Inventory

    Measured: 4 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Feb 2024
  2. Study start1 Nov 2023
  3. Primary completion1 Oct 2025 (estimated)
  4. Study completion1 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06258382
Sponsor's protocol ID
2023-02526-01
Other IDs
2023
Status last verified
Oct 2024
First submitted
6 Feb 2024
Last updated
16 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Fontan Circulation, run by Caroline Lilliecreutz at 15 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 15 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Caroline Lilliecreutz, PhD, Docent (+46708731124, caroline.lilliecreutz@regionostergotland.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence and explanatory factors for sexual dysfunction and infertility in women and men with Fontan circulation (time frame: 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in